Literature DB >> 17683791

Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.

Jackie Gour1, Roderick Edwards, Sarah Lemieux, Mehrdad Ghassemi, Mandar Jog, Christian Duval.   

Abstract

The present study characterized involuntary movements associated with levodopa-induced dyskinesias (LID) in patients with Parkinson's disease. We used amplitude, proportional energy, frequency dispersion and sample entropy to determine whether LID movement patterns are truly random, as clinical description seems to suggest, or possess some underlying pattern that is not visible to the naked eye. LID was captured using a magnetic tracker system, which provided 3D rendering of whole-body LID. Patients were instructed to maintain a standing position, with arms extended in front of them. We compared the measurements of the dyskinetic PD group (DPD) with 10 patients without dyskinesias (NDPD) and 10 control subjects. In comparison to the other two groups, movement patterns from the DPD group had significantly higher amplitude, confirming the presence of dyskinesias. In addition, higher frequency components in the power spectrum of velocity were detected, suggestive of higher velocity in LID movement. Furthermore, there was a concentration in narrow frequency bands, which suggested stable oscillatory activity. Finally, sample entropy revealed more regularity in the DPD group. Although not statistically significant, we found that the amplitude from the NDPD group had a tendency to be smaller than those of controls. As well, the spectra were often more dispersed for the NDPD group. In conclusion, the present results suggest that LID cannot be considered as purely random movement since they possess some deterministic pattern of motion. This may provide a way for patients to adapt to these involuntary movements while performing voluntary motor acts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683791     DOI: 10.1016/j.brainresbull.2007.05.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

Review 1.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

2.  Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia.

Authors:  Rena K Mann; Roderick Edwards; Julie Zhou; Alison Fenney; Mandar Jog; Christian Duval
Journal:  Exp Brain Res       Date:  2012-03-21       Impact factor: 1.972

3.  Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication.

Authors:  James K R Stevenson; Pouria Talebifard; Edna Ty; Meeko M K Oishi; Martin J McKeown
Journal:  Exp Brain Res       Date:  2011-08-30       Impact factor: 1.972

4.  Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.

Authors:  Christopher L Pulliam; Dustin A Heldman; Elizabeth B Brokaw; Thomas O Mera; Zoltan K Mari; Michelle A Burack
Journal:  IEEE Trans Biomed Eng       Date:  2017-04-25       Impact factor: 4.538

5.  PERFORM: a system for monitoring, assessment and management of patients with Parkinson's disease.

Authors:  Alexandros T Tzallas; Markos G Tsipouras; Georgios Rigas; Dimitrios G Tsalikakis; Evaggelos C Karvounis; Maria Chondrogiorgi; Fotis Psomadellis; Jorge Cancela; Matteo Pastorino; María Teresa Arredondo Waldmeyer; Spiros Konitsiotis; Dimitrios I Fotiadis
Journal:  Sensors (Basel)       Date:  2014-11-11       Impact factor: 3.576

6.  A New Evolutionary Algorithm-Based Home Monitoring Device for Parkinson's Dyskinesia.

Authors:  Michael A Lones; Jane E Alty; Jeremy Cosgrove; Philippa Duggan-Carter; Stuart Jamieson; Rebecca F Naylor; Andrew J Turner; Stephen L Smith
Journal:  J Med Syst       Date:  2017-09-25       Impact factor: 4.460

7.  Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.

Authors:  Shi-Ying Fan; Kai-Liang Wang; Wei Hu; Robert S Eisinger; Alexander Han; Chun-Lei Han; Qiao Wang; Shimabukuro Michitomo; Jian-Guo Zhang; Feng Wang; Adolfo Ramirez-Zamora; Fan-Gang Meng
Journal:  Ann Clin Transl Neurol       Date:  2019-12-08       Impact factor: 4.511

8.  Quantitative Measurement of Akinesia in Parkinson's Disease.

Authors:  Lissette Lalvay; Miguel Lara; Andrea Mora; Fernando Alarcón; Manuel Fraga; Jesús Pancorbo; José Luis Marina; María Ángeles Mena; Jose Luis Lopez Sendón; Justo García de Yébenes
Journal:  Mov Disord Clin Pract       Date:  2016-08-03

Review 9.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.